Joshua Samsoondar
@jsamsoondar
Followers
495
Following
7K
Media
200
Statuses
3K
@ucalgary Gen Path resident, @westernu biochem BMSc MSc MD. Interests: metabolism biotech theology volleyball podcasts innovation All for the soli Deo gloria
Ontario, Canada
Joined December 2014
🎉#PathTweetAward Check out these amazing educational tweets for October 2025 #PathTweetAward 📷@cebulka26 @smlungpathguy @GIJamesMD @adi_agnihotri @ariella8 @archibhat3 @LakshmiKoulmane @pembeoltulu @VijayPatho @VHNguyenMD @ahsanuitis @PoojaSMD @ThatGlassTho @jsamsoondar
4
13
27
Everything you've said is fine Dr. Koka but what exactly does that have to do with @PeterAttiaMD's post? He's talking about risk prediction and prevention and you're talking about acute events and stents...
The problem with the value proposition for coronary CTA is that in reality the use case is mostly limited to low risk (young) people presenting with chest pain to the ER. That use case shrank with the advent of high sensitivity troponins. Everything else is essentially made
0
0
0
After years of following both @drjohnm & @PeterAttiaMD, would love to see them discuss this together. Their approach to CAC and questions they seek to answer are entirely different. Many things I'd like to ask both, and try to tease out if there's a middle ground they'd agree on.
If every CT scanner in the US broke down for a year, heart disease deaths would not change. The prevalence of soft thinking amongst doctors is shocking https://t.co/nWVjNaf9ka
0
0
0
absolutely phenomenal talk by @KayKoMD at @BanffPathCourse his willingness to use the tools available to us (ie p16 and p53) is really resonating with me so many pearls in his talk, impressive job addressing expected responses and delving into technical aspects
0
0
2
Check out this compilation of educational path tweets - July 2025 collection. #Pathtweetaward
3
29
64
Fantastic thread for the pathology trainees as well, since most of what we do pertains to cancer diagnoses and it can often be unclear what a diagnosis means for the patient when there are so many treatment options and when inpatient chemo is appropriate.
🎗️Oncology for The Non-Oncologist🎗️ (A practical educational series for internal medicine trainees and physicians) Episode 4: Which cancers need emergent inpatient chemo? Here’s your answer. Listen up - 🧵
0
1
3
1/ 33🧵 Check out this fantastic collection of educational tweets from the global 🌏 #PathTweetAward for June 2025. #Pathology #PTAJune2025 🔬 @PathTweetAward @cebulka26 @smlungpathguy
4
24
34
After getting a ton of nominations for March 2025, the Trainee #PathTweetAward goes to @TheShorePath! https://t.co/FovED5V2Px
Saw 2 of these cases in 2 weeks earlier this year. Both patients had recently immigrated from South America and presented with enlarging ulcerative lesions on their upper extremities. Diagnosis? #pathology #PathX #dermpath #pathmatch2025
1
0
17
Why some of the regenerated myofibers (NOD🐁 1 month post-ischemia) are so hematoxyphilic!?😳
2
5
22
95/
#1 of 2 Macule on the cheek. Diagnosis? A) Solar lentigo B) Lentigo simplex C) Junctional nevus #DermPath #PathTwitter #Pathology
1
0
1
93/
This hepatic solitary fibrous tumors is infiltrative and has resulted in obstructed ducts - the appearance is not in line with that of mesenchymal hamartoma, which has more stellate mesenchymal cells. #UMiamiPath @ModernPathology
1
0
1
91/
History of breast cancer and radiation therapy. Benign or malignant? #BreastPath #DermPath #BSTPath #PathTwitter #Pathology
1
0
1
90/
Part 1 of 2: 63M, left pre-mastoid lesion. What is your interpretation of the FNA?💉🔬 A) Non-Diagnostic B) Neoplasm - Benign C) Neoplasm - SUMP D) Malignant #CytoPath #PathTwitter
1
0
1
89/
Same cells, different stains Russell bodies (H&E) vs Mott cells (Giemsa). These Ig-stuffed plasma cells are gorgeous 👌🏼 #hemepath
1
0
1
88/
Large, slimy, and glistening hypermucoid colonies of S pneumoniae on blood agar. #Fortheloveofmicrobiology #clinicalmicrobiology #mmidsp #microrounds #IDpath #ASMClinMicro #STEM #WomeninMicrobiology #ClinMicro #microbiologypakistan #PathBugs
1
0
1